James Bowers, MD
Orthopaedic Surgery · Burlington, NCNPI 1134138753
Payments from drug & device makers
Across 42 payments — averaging $151.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$4K
- Johnson & Johnson$1K
- Linvatec Corporation$727
- Stryker$195
- Medical Device Business Services, Inc.$66
- Pacira Pharmaceuticals Incorporated$26
- plus $20 from 1 others
What the payments were for
- Travel & lodging$4,77075%
- Food & beverage$1,58025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 18 | $4,094 |
| Johnson & Johnson | 10 | $1,223 |
| Linvatec Corporation | 5 | $727 |
| Stryker | 4 | $195 |
| Medical Device Business Services, Inc. | 3 | $66 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Pacira Therapeutics, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Legion Revision$2,299
- REAL INTELLIGENCE$1,299
- OR3O Dual Mobility$1,168
- JOURNEY$1,024
- REDAPT$1,024
- CORAIL$1,009
- PINNACLE$1,009
- Kincise Surgical Automated System$1,009
- VELYS Hip Navigation$1,009
- LINVATEC KNEE PRESERVATION SYSTEM$510
- LINVATEC SHOULDER ARTHROSCOPY$510
- Journey II$293
- Legion$201
- Navio Surgical System$201
- Journey Uni$201
- REDAPT Revision Hip System$201
- MAKO$147
- Journey II BCS$124
How this compares
$6,350 in reported general payments places this provider in the 50th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 191 | $2,636 |
| Meloxicam | 433 | $1,235 |
| Methocarbamol | 144 | $758 |
| Methylprednisolone | 129 | $751 |
| Tizanidine Hcl | 101 | $674 |
| Tramadol Hcl | 213 | $656 |
| Diclofenac Sodium | 22 | $349 |
| Gabapentin | 57 | $333 |
| Naproxen | 21 | $280 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $261 |
| Oxycodone Hcl | 30 | $132 |
| Amoxicillin | 19 | $29 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Burlington
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$6.2M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$5.2M
- Mark EasleyDurham$4.2M
- Carroll JonesCharlotte$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.